Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Genetic Tech Spn ADR (NQ: GENE )

0.7455 -0.0096 (-1.27%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 4, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Genetic Tech Spn ADR

< Previous 1 2 3 4 Next >
Marijuana Stock Movers For September 29, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For September 28, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Genetic Technologies building pathway to profitability
--News Direct-- 
Via News Direct
Genetic Technologies building pathway to profitability
Genetic Technologies Ltd (ASX:GTG; NASDAQ:GENE) CEO Simon Morriss tells Proactive the focus over the next 18 years is putting the pathway in place to see the business on track to profitability. GTG... 
Via TheNewswire.com
GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network
From Genetic Technologies Ltd
Via GlobeNewswire
Cannabis Stock Movers For September 15, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Aridis Pharmaceuticals, Inc., Genetic Technologies Limited, and American Resources Corporation Interviews to Air on the RedChip Money Report® on Bloomberg TV
Via ACCESSWIRE
Why Mainz Biomed Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares rose 38.7% to $0.1713 in pre-market trading. Shares of Avalo Therapeutics jumped over 45% on Tuesday after the company agreed to divest AVTX-800... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another dive into the biggest pre-market stock movers as we check out all the shares worth watching on Wednesday! 
Via InvestorPlace
Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
From Genetic Technologies Ltd
Via GlobeNewswire
Bullish Sentiment Across The Cannabis Space - Check Full Movers For September 11, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner
Trial to Assess Multi Cancer Genetic Risk Assessment in General Practice 
From Genetic Technologies Ltd
Via GlobeNewswire
Cannabis Stock Movers For September 6, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For September 4, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Friday For Marijuana Stocks - AusCann Group Holdings, Affinor Growers Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
Via ACCESSWIRE
Bullish Thursday For Marijuana Stocks - Australis Capital, Choom Holdings Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Annual Results – Momentum Building on our Commercial Plans
From Genetic Technologies Ltd
Via GlobeNewswire
Cannabis Stock Movers For August 29, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Genetic Technologies Limited Announces Updated Investor Presentation
From Genetic Technologies Ltd
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
  On Friday, 73 companies reached new 52-week lows. 
Via Benzinga
Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
From Genetic Technologies Ltd
Via GlobeNewswire
Cannabis Stock Gainers And Losers From July 14, 2023
Via Benzinga
GeneType featured on U.S. National TV to raise Breast Cancer Awareness
From Genetic Technologies Ltd
Via GlobeNewswire
New Publication Validates geneType for Melanoma Risk Assessment
From Genetic Technologies Ltd
Via GlobeNewswire
Quarterly Business Update – March 2023
Driving growth, Expanded Multi-Test Panel and Publications Validating Clinical Utility of geneType 
From Genetic Technologies Ltd
Via GlobeNewswire
Publication Validates geneType Prostate Cancer Risk Test
From Genetic Technologies Ltd
Via GlobeNewswire
GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation
From Genetic Technologies Ltd
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.